Provided by Tiger Trade Technology Pte. Ltd.

Cardinal Health

234.55
0.0000
Volume:580.06K
Turnover:136.73M
Market Cap:54.55B
PE:32.44
High:236.96
Open:236.00
Low:233.51
Close:234.55
52wk High:258.30
52wk Low:145.87
Shares:232.58M
Float Shares:232.58M
Volume Ratio:0.46
T/O Rate:0.25%
Dividend:2.05
Dividend Rate:0.87%
EPS(TTM):7.23
EPS(LYR):7.23
ROE:-171.32%
ROA:3.72%
PB:-18.92
PE(LYR):32.44

Loading ...

Cardinal Health Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Jul 15

Cardinal Health is Maintained at Buy by TD Cowen

Dow Jones
·
Jul 10

TD Cowen Adjusts Price Target on Cardinal Health to $275 From $255

MT Newswires Live
·
Jul 09

Cardinal Health to Report Fiscal 2026 Fourth-quarter, Year-end Results, Host Webcast

Reuters
·
Jul 09

Cardinal Health Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jul 09

Evercore ISI Adjusts Price Target on Cardinal Health to $265 From $240

MT Newswires Live
·
Jul 07

Is Cardinal Health (CAH) Fully Valued After Its Russell Index Removal?

Simply Wall St.
·
Jul 04

Cardinal Health is Maintained at Buy by B of a Securities

Dow Jones
·
Jul 02

BofA Securities Adjusts Cardinal Health Price Target to $260 From $240

MT Newswires Live
·
Jul 02

Bank of America Securities Reaffirms Their Buy Rating on Cardinal Health (CAH)

TIPRANKS
·
Jul 02

Neurocrine Begins Phase 2 Trial of Crinecerfont in Children Under 4 Years With Classic CAH Genetic Condition

MT Newswires Live
·
Jul 02

Cardinal Health Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jun 27

Cardinal Health Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jun 25

Cardinal Health Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jun 24

What Neurocrine Biosciences (NBIX)'s New CRENESSITY CAH Data Means For Shareholders

Simply Wall St.
·
Jun 22

Cardinal Health Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Jun 19

Cardinal Health Inc. Stock Rises Monday, Still Underperforms Market

Dow Jones
·
Jun 16

Crinetics Presents Full Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH) in Oral Presentation at ENDO 2026

GlobeNewswire
·
Jun 15

Cardinal Health Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jun 13

William O'Neil Initiates Cardinal Health at Buy

MT Newswires Live
·
Jun 12